EcoDrugPlus

Carbonic Anhydrase 4-Like

Ensembl ID : ENSOKIG00005037012
Gene Symbol: LOC109873354
3 Cross references
207 Possible Orthologues:

Carbonic Anhydrase 5b, Mitochondrial

Ensembl ID : ENSOKIG00005031624
Gene Symbol: LOC109889254
3 Cross references
225 Possible Orthologues:

Carbonic Anhydrase 5b, Mitochondrial-Like

Ensembl ID : ENSOKIG00005046377
Gene Symbol: LOC109867236
3 Cross references
225 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSOKIG00005012088
Gene Symbol: CA6
3 Cross references
207 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSOKIG00005038886
Gene Symbol: CA6
1 Cross references
207 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSOKIG00005023449
Gene Symbol: LOC109895025
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 7-Like

Ensembl ID : ENSOKIG00005010755
Gene Symbol: LOC109872813
3 Cross references
214 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSOKIG00005001426
Gene Symbol: CA14
1 Cross references
202 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSOKIG00005010746
Gene Symbol: CSNK1E
3 Cross references
208 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSOKIG00005015117
Gene Symbol: CSNK1E
3 Cross references
208 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSOKIG00005011762
Gene Symbol: CSNK1E
1 Cross references
190 Possible Orthologues:

Casein Kinase I-Like

Ensembl ID : ENSOKIG00005006292
Gene Symbol: LOC109869937
3 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).